tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Revenue

Compare
1,212 Followers

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had a revenue of 207.00M in the quarter ending Dec 31, 2025, with 29.43%. This bring the company's revenue in the last twelve months to 672.72M, Decreased 6.68%. In the fiscal year ending Dec 31, 2025, Ultragenyx Pharmaceutical had annual revenue of 673.00M with 20.13% growth.
Revenue (ttm)
672.72M
Revenue Growth
20.63%
P/S Ratio
2.85
Revenue/Employee
$520,093
Employees
1,294
Market Cap
$1.92B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
673.00M112.77M+20.13%
Dec 31, 2024
560.23M125.98M+29.01%
Dec 31, 2023
434.25M70.92M+19.52%
Dec 31, 2022
363.33M11.92M+3.39%
Dec 31, 2021
351.41M80.38M+29.66%
Dec 31, 2020
271.03M167.32M+161.32%
Dec 31, 2019
103.71M52.22M+101.41%
Dec 31, 2018
51.49M48.88M+1,871.48%
Dec 31, 2017
2.61M